Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The many roads to cross-presentation.

Tom A M Groothuis1, Jacques Neefjes

  • 1Div. of Tumor Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands.

The Journal of Experimental Medicine
|November 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The murine MHC-E molecule Qa-1<sup>b</sup> is surface displayed in a peptide-free conformation in homeostasis.

Frontiers in immunology·2026
Same author

Setting higher standards for reports of microbial species in human cancers.

Nature cancer·2026
Same author

Metabolic engineering of doxorubicin biosynthesis through P450-redox partner optimization and structural analysis of DoxA.

Nature communications·2026
Same author

The trajectory of fatigue over time in breast cancer patients treated with chemotherapy: exploring the effect of anthracycline-based chemotherapy.

Breast (Edinburgh, Scotland)·2026
Same author

Cell cycle arrest enhances CD8<sup>+</sup> T cell effector function by potentiating glucose metabolism and IL-2 signaling.

Nature immunology·2026
Same author

Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies.

Pediatric blood & cancer·2025
Same journal

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same journal

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same journal

Flawed translation triggers oncogenic B-T cell communication.

The Journal of experimental medicine·2026
Same journal

Correction: LCK'ed in: Inborn errors of immunity in LCK reveal how TCR signaling is calibrated.

The Journal of experimental medicine·2026
Same journal

Mechanobiology of inflammation: Pulling the strings of innate immunity.

The Journal of experimental medicine·2026
Same journal

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

The Journal of experimental medicine·2026
See all related articles

Cross-presentation of extracellular antigens by MHC class I molecules primes cytotoxic T lymphocytes (CTLs). This review discusses the ER-phagosome fusion hypothesis and alternative mechanisms for cross-presentation.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Cross-presentation of extracellular antigens by Major Histocompatibility Complex (MHC) class I molecules is crucial for initiating adaptive immune responses, particularly for priming cytotoxic T lymphocytes (CTLs).
  • This process is essential for immune surveillance and response initiation at sites distant from the initial antigen encounter.

Purpose of the Study:

  • To critically evaluate the evidence supporting and refuting the endoplasmic reticulum (ER)-phagosome fusion model for cross-presentation.
  • To explore and discuss alternative proposed mechanisms of cross-presentation.

Main Methods:

  • This study is a review and discussion of existing literature and proposed mechanisms.
  • Analysis of experimental evidence for and against the ER-phagosome fusion concept.

Related Experiment Videos

Main Results:

  • The ER-phagosome fusion model proposes direct delivery of MHC class I loading machinery into the phagosome.
  • Evidence for and against this specific mechanism is debated within the scientific community.
  • Other potential pathways for antigen cross-presentation are also considered.

Conclusions:

  • The precise mechanisms governing cross-presentation remain an active area of research.
  • Understanding these pathways is vital for developing effective immunotherapies and vaccines.